Tremors are one of the most difficult multiple sclerosis (MS) symptoms to treat. Several medications exist to treat tremors, but not much is known about their ability to consistently reduce symptoms. This can be confusing for MS patients who experience tremors.

Risk of Alzheimer’s disease (AD) increases with age, but the way the disease progresses varies. Some people with AD start having symptoms in their sixties and others much later.

Are you having problems getting around due to your multiple sclerosis (MS)? Many people living with MS report mobility as a common problem. Increasing mobility in people living with MS first requires pinpointing the reasons behind it.

Simple memories, like being able to identify a smell, can be affected in later stages of dementia. However, research suggests that changes in smell memory may show up early.

Many women do not seek medical care for urinary incontinence as they may not feel like it is a priority medical issue or they may feel too embarrassed to address it. Addressing the problem can help patients improve their quality of life, especially for those who are living with other medical conditions such as multiple sclerosis (MS).

Could treatment for Parkinson’s disease (PD) be as easy as a cup of coffee? Caffeine will not cure PD but a recent study shows that it may ease the motor symptoms such as tremor, rigidity and slowness of movement that characterize the disease. 

Aricept is approved for the treatment of Alzheimer’s disease, but clinical trials are underway to see if it will be helpful for other types of dementia.

Most people are aware of the tremors and other motor symptoms associated with Parkinson’s disease (PD), but the cognitive aspects of the condition often receive much less attention. For those with PD, understanding cognitive symptoms like apathy and impulsivity can be vital to improving their quality of life.

Surgery to replace a damaged hip or knee can put an end to the pain of osteoarthritis. But, like any surgery, there are risks involved.

The APoE4 gene increases the risk of Alzheimer’s disease (AD) and is thought to influence how quickly AD progresses, but a new drug failed to help people with this gene.